Hans Christian Pedersen

Author

Edinburgh Cancer Research

Also Known As

H Pedersen, H.C. Pedersen, Hans C. Pedersen, Hans Christian B. Pedersen, Hans Christian Pedersen

Publications

428

Citations

H-Index

Concepts

All Affiliations

Edinburgh Cancer Research Western General Hospital

About

Hans Christian Pedersen is an author at Edinburgh Cancer Research specializing in medicine, pharmacotherapy, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	113
2	Engineering	1	1	14
3	Health Sciences	1	1	20
4	Natural Sciences	1	1	14
5	Biomedical Engineering	1	1	14

Hans Christian Pedersen

Publications

421

Citations

H-Index

Page 1

	Year	Citations
Mammostrat®as a tool to stratify breast cancer patients at risk of recurrence during endocrine therapy John M.S. Bartlett, Jeremy Thomas, Douglas T. Ross, Breast Cancer Research	2010	118
Genetic and Environmental Contributions to Back Pain in Old Age Jan Hartvigsen, Kaare Christensen, Henrik Frederiksen, Spine	2004	59
Human epidermal growth factor receptor 2 (HER2) immunoreactivity: specificity of three pharmacodiagnostic antibodies Anne‐Sofie Schrohl, Hans Christian Pedersen, Sussie Steen Jensen, Histopathology	2011	47
Phase I clinical trial of a new antitumor agent, 4'-demethylepipodophyllotoxin 9-(4,6-O-ethylidene- -D-glucopyranoside) (NSC-141540; VP-16-213). N. I. Nissen, V Larsen, Hans Christian Pedersen, PubMed Medicinal ChemistryOncology4'-Demethylepipodophyllotoxin 9-MedicinePharmacotherapy	1972	42
Optimal protocol for PTEN immunostaining; role of analytical and preanalytical variables in PTEN staining in normal and neoplastic endometrial, breast, and prostatic tissues Óscar Maiques, Marı́a Santacana, Joan Valls, Human Pathology	2013	39
Technology generation to dissemination: lessons learned from the tef improvement project Gina Cannarozzi, Solomon Chanyalew, Kebebew Assefa, Euphytica	2018	31
Clinical trial of the oral form of a new podophyllotoxin derivative, VP-16-213 (NSC-141540), in patients with advanced neoplastic disease. N. I. Nissen, H H Hansen, Hans Christian Pedersen, PubMed OncologyNew PodophyllotoxinMedicineClinical TrialsPathology	1976	30
Phase I trial of a new form of an oral administration of VP-16-213. Lau Me, Hansen Hh, Nissen Ni, PubMed Pharmaceutical ScienceNew FormMedicineNew Oral FormVp-16-213 Solution	1979	21
Impact of Screening and Risk Factors for Local Recurrence and Survival After Conservative Surgery and Radiotherapy for Early Breast Cancer: Results From a Large Series With Long-Term Follow-Up Ian Kunkler, G.R. Kerr, Jeremy Thomas, International Journal of Radiation OncologyBiologyPhysics Surgical OncologyBreast OncologyCancer ScreeningCancer RecurrenceLarge Series	2011	20
Improved Catalyzed Reporter Deposition, iCARD Jesper Lohse, Kenneth H. Petersen, Nina Claire Woller, Bioconjugate Chemistry Immunocytochemical TechniqueEngineeringMolecular BiologyHer2 ProteinsNovel Reporters	2014	14

Page 1